Seattle Genetics

Are Biotech M&A Premiums Already Built In? Valuations Do Matter
Seeking Alpha
Tue, 09/3/13 - 04:19 pm
biotech
M&A
ONYX Pharmaceuticals
Alexion
Biomarin
Incyte
Medivation
Pharmacyclics
Regeneron
Seattle Genetics
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
These biotech names are ripe for takeover: Cramer
CNBC
Wed, 08/28/13 - 09:50 am
M&A
Amgen
ONYX Pharmaceuticals
Medivation
Astellas
Seattle Genetics
Biotech Buyouts: Who's Next?
Motley Fool
Thu, 08/22/13 - 05:35 pm
M&A
ONYX Pharmaceuticals
Amgen
Seattle Genetics
Medivation
Incyte
Seattle Genetics, Astellas affiliate announce co-development of added ADC
The Fly on the Wall
Thu, 06/27/13 - 10:37 am
Seattle Genetics
antibody-drug conjugate
Astellas
ASG-15ME
Agensys
bladder cancer
lung cancer
Safety Concern Halts Study of Seattle Genetics' Lymphoma Drug
TheStreet.com
Tue, 06/25/13 - 12:19 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Seattle Genetics, Bayer to Develop Less Symptomatic Cancer Drug
FOX Business
Tue, 06/25/13 - 12:18 pm
Seattle Genetics
Bayer
antibody-drug conjugate
Seattle Genetics highlights ADCETRIS data at lymphoma conference
Yahoo/Fly on the Wall
Fri, 06/21/13 - 09:14 am
Seattle Genetics
Adcetris
lymphoma
A Trio of Cancer Immunotherapy Innovators
Motley Fool
Sat, 06/15/13 - 01:02 pm
Immunogen
Seattle Genetics
Celldex
Seattle Genetics Highlights Adcetris (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/2/13 - 11:43 am
Seattle Genetics
Adcetris
T-cell lymphoma
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Narrower-than-Expected Loss at Seattle Genetics
Yahoo/Zacks
Wed, 05/8/13 - 10:50 am
Seattle Genetics
earnings
Declines From Seattle Genetics Inc. (SGEN) Drive Down Health Care Sector
TheStreet.com
Fri, 03/29/13 - 11:23 am
Seattle Genetics
Anything Can Happen This Year For Celldex
Seeking Alpha
Mon, 02/18/13 - 12:18 pm
Celldex
breast cancer
CDX-110
CDX-111
Seattle Genetics
Five Super Ideas in the Healthcare Sector
Motley Fool
Wed, 02/13/13 - 10:21 am
Eli Lilly
Merck
Forest Labs
Regeneron
Seattle Genetics
Seattle Genetics Initiates Two Phase I Trials of SGN-CD19A
Yahoo
Wed, 02/6/13 - 11:07 am
Seattle Genetics
SGN-CD19A
acute lymphoblastic leukemia
non-Hodgkin B-cell lymphoma
4 Healthcare Stock Stories for TGIF Wellness
Wall Street Cheat Street
Sat, 02/2/13 - 11:46 am
Vertex Pharmaceuticals
Seattle Genetics
Echo Therapeutics
Santarus
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Biotech Corner: Monoclonal Antibody Companies
Seeking Alpha
Wed, 12/12/12 - 10:19 am
monoclonal antibodies
Adcetris
Seattle Genetics
Progenics
Seattle Genetics to test possible new Adcetris use in late-stage study
Yahoo/AP
Mon, 12/10/12 - 12:04 pm
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma

Pages